These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 28630039)
1. Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells. Wallin H; Apelqvist J; Andersson F; Ekström U; Abrahamson M J Biol Chem; 2017 Sep; 292(35):14413-14424. PubMed ID: 28630039 [TBL] [Abstract][Full Text] [Related]
2. Cystatin C properties crucial for uptake and inhibition of intracellular target enzymes. Wallin H; Abrahamson M; Ekström U J Biol Chem; 2013 Jun; 288(23):17019-17029. PubMed ID: 23629651 [TBL] [Abstract][Full Text] [Related]
3. Cystatin E/M suppresses legumain activity and invasion of human melanoma. Briggs JJ; Haugen MH; Johansen HT; Riker AI; Abrahamson M; Fodstad Ø; Maelandsmo GM; Solberg R BMC Cancer; 2010 Jan; 10():17. PubMed ID: 20074384 [TBL] [Abstract][Full Text] [Related]
4. Intra- and extracellular regulation of activity and processing of legumain by cystatin E/M. Smith R; Johansen HT; Nilsen H; Haugen MH; Pettersen SJ; Mælandsmo GM; Abrahamson M; Solberg R Biochimie; 2012 Dec; 94(12):2590-9. PubMed ID: 22902879 [TBL] [Abstract][Full Text] [Related]
5. Silencing of cystatin M in metastatic oral cancer cell line MDA-686Ln by siRNA increases cysteine proteinases and legumain activities, cell proliferation and in vitro invasion. Vigneswaran N; Wu J; Nagaraj N; James R; Zeeuwen P; Zacharias W Life Sci; 2006 Jan; 78(8):898-907. PubMed ID: 16150465 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of mammalian legumain by some cystatins is due to a novel second reactive site. Alvarez-Fernandez M; Barrett AJ; Gerhartz B; Dando PM; Ni J; Abrahamson M J Biol Chem; 1999 Jul; 274(27):19195-203. PubMed ID: 10383426 [TBL] [Abstract][Full Text] [Related]
7. Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification. Cheng T; Hitomi K; van Vlijmen-Willems IM; de Jongh GJ; Yamamoto K; Nishi K; Watts C; Reinheckel T; Schalkwijk J; Zeeuwen PL J Biol Chem; 2006 Jun; 281(23):15893-9. PubMed ID: 16565075 [TBL] [Abstract][Full Text] [Related]
8. Cystatins--Extra- and intracellular cysteine protease inhibitors: High-level secretion and uptake of cystatin C in human neuroblastoma cells. Wallin H; Bjarnadottir M; Vogel LK; Wassélius J; Ekström U; Abrahamson M Biochimie; 2010 Nov; 92(11):1625-34. PubMed ID: 20800088 [TBL] [Abstract][Full Text] [Related]
9. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases. Pavlova A; Björk I Biochemistry; 2003 Sep; 42(38):11326-33. PubMed ID: 14503883 [TBL] [Abstract][Full Text] [Related]
10. Glycosylation is important for legumain localization and processing to active forms but not for cystatin E/M inhibitory functions. Lunde NN; Haugen MH; Bodin Larsen KB; Damgaard I; Pettersen SJ; Kasem R; Rut W; Drag M; Poreba M; Johansen HT; Solberg R Biochimie; 2017 Aug; 139():27-37. PubMed ID: 28528272 [TBL] [Abstract][Full Text] [Related]
11. Internalization of cystatin C in human cell lines. Ekström U; Wallin H; Lorenzo J; Holmqvist B; Abrahamson M; Avilés FX FEBS J; 2008 Sep; 275(18):4571-82. PubMed ID: 18699780 [TBL] [Abstract][Full Text] [Related]
12. Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells. Shridhar R; Zhang J; Song J; Booth BA; Kevil CG; Sotiropoulou G; Sloane BF; Keppler D Oncogene; 2004 Mar; 23(12):2206-15. PubMed ID: 14676833 [TBL] [Abstract][Full Text] [Related]
13. Evidence that unrestricted legumain activity is involved in disturbed epidermal cornification in cystatin M/E deficient mice. Zeeuwen PL; van Vlijmen-Willems IM; Olthuis D; Johansen HT; Hitomi K; Hara-Nishimura I; Powers JC; James KE; op den Camp HJ; Lemmens R; Schalkwijk J Hum Mol Genet; 2004 May; 13(10):1069-79. PubMed ID: 15044380 [TBL] [Abstract][Full Text] [Related]
14. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas. Trinkaus M; Vranic A; Dolenc VV; Lah TT Int J Biol Markers; 2005; 20(1):50-9. PubMed ID: 15832773 [TBL] [Abstract][Full Text] [Related]
15. Expression of cysteine proteinases and their inhibitor, cystatin beta, in cultured rat mesangial cells. Makita Y; Ishidoh K; Kominami E; Funabiki K; Koide H; Tomino Y J Diabetes Complications; 1998; 12(6):328-36. PubMed ID: 9877467 [TBL] [Abstract][Full Text] [Related]
16. Probing the functional role of the N-terminal region of cystatins by equilibrium and kinetic studies of the binding of Gly-11 variants of recombinant human cystatin C to target proteinases. Björk I; Brieditis I; Abrahamson M Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):513-8. PubMed ID: 7887904 [TBL] [Abstract][Full Text] [Related]
17. Decreased activity of cathepsins L + B and decreased invasive ability of PC3 prostate cancer cells. Colella R; Casey SF Biotech Histochem; 2003 Apr; 78(2):101-8. PubMed ID: 14533846 [TBL] [Abstract][Full Text] [Related]
18. Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases. Mason RW; Sol-Church K; Abrahamson M Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):833-8. PubMed ID: 9480898 [TBL] [Abstract][Full Text] [Related]
19. Externally added cystatin C reduces growth of A375 melanoma cells by increasing cell cycle time. Wallin H; Hunaiti S; Abrahamson M FEBS Open Bio; 2021 Jun; 11(6):1645-1658. PubMed ID: 33837649 [TBL] [Abstract][Full Text] [Related]
20. On Blastocystis secreted cysteine proteases: a legumain-activated cathepsin B increases paracellular permeability of intestinal Caco-2 cell monolayers. Nourrisson C; Wawrzyniak I; Cian A; Livrelli V; Viscogliosi E; Delbac F; Poirier P Parasitology; 2016 Nov; 143(13):1713-1722. PubMed ID: 27609526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]